SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Rennova Health, Inc. 
 FL
  SEC # 931059


        
1  Related Registrant:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

136  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
5/16/23424B31About This Prospectus
1Business
1Cautionary Statement Concerning Forward-Looking Statements
1Certain Relationships and Related Party Transactions
4/17/2310-K1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
8/15/2310-Q1Condensed Consolidated Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022
5/15/2310-Q1Condensed Consolidated Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022
11/14/2310-Q1Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022
1Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited)
8/15/2310-Q1Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022 (unaudited)
5/15/2310-Q1Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (unaudited)
11/14/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Deficit for each of the quarters in the nine-month periods ended September 30, 2023 and 2022 (unaudited)
8/15/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Deficit for each of the quarters in the six-month periods ended June 30, 2023 and 2022 (unaudited)
5/15/2310-Q1Condensed Consolidated Statements of Changes in Stockholders' Deficit for the three months ended March 31, 2023 and 2022 (unaudited)
11/14/2310-Q1Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022 (unaudited)
8/15/2310-Q1Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022 (unaudited)
5/15/2310-Q1Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022 (unaudited)
4/17/2310-K1Consolidated Balance Sheets as of December 31, 2022 and 2021
1Consolidated Statements of Cash Flows for the Years Ended December 31, 2022 and 2021
1Consolidated Statements of Operations for the Years Ended December 31, 2022 and 2021
1Consolidated Statements of Stockholders' Deficit for the Years Ended December 31, 2022 and 2021
11/14/2310-Q1Controls and Procedures
1Defaults Upon Senior Securities
5/16/23424B31Description of Capital Stock
1Description of the Securities We Are Offering
4/17/2310-K1Directors, Executive Officers and Corporate Governance
1Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
5/16/23424B31Executive Compensation
11/14/2310-Q1Exhibits
4/17/2310-K1Exhibits and Financial Statement Schedules
5/16/23424B31Experts
11/14/2310-Q1Financial Information
1Financial Statements
4/17/2310-K1Financial Statements and Supplementary Data
1Form 10-K Summary
5/16/23424B31Incorporation of Certain Information by Reference
1Legal Matters
11/14/2310-Q1Legal Proceedings
5/16/23424B31Management
11/14/2310-Q1Management's Discussion and Analysis of Financial Condition and Results of Operations
4/17/2310-K1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
5/16/23424B31Market Price for Common Equity and Related Stockholder Matters
11/14/2310-Q1Mine Safety Disclosures
1Notes to Condensed Consolidated Financial Statements (unaudited)
4/17/2310-K1Notes to Consolidated Financial Statements
11/14/2310-Q1Other Information
4/17/2310-K1Part I
11/14/2310-Q1Part I -- Financial Information
4/17/2310-K1Part Ii
11/14/2310-Q1Part Ii -- Other Information
4/17/2310-K1Part Iii
1Part Iv
5/16/23424B31Plan of Distribution
5/9/23S-1/A1Power of Attorney for Rennova Health, Inc. (included on the signature page of the Registration Statement)(2)
4/17/2310-K1Principal Accountant Fees and Services
5/16/23424B31Principal Stockholders
4/17/2310-K1Properties
5/16/23424B31Prospectus Summary
11/14/2310-Q1Quantitative and Qualitative Disclosures About Market Risk
4/17/2310-K1Report of Independent Registered Public Accounting Firm
1Reserved
11/14/2310-Q1Risk Factors
4/17/2310-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
5/16/23424B31Selling Stockholders
1Shares Eligible for Future Sale
11/14/2310-Q1Signatures
1Unregistered Sales of Equity Securities and Use of Proceeds
4/17/2310-K1Unresolved Staff Comments
5/16/23424B31Use of Proceeds
1Where You Can Find Additional Information

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 8:11:48.1am ET